FR2113883B1 - - Google Patents

Info

Publication number
FR2113883B1
FR2113883B1 FR7140157A FR7140157A FR2113883B1 FR 2113883 B1 FR2113883 B1 FR 2113883B1 FR 7140157 A FR7140157 A FR 7140157A FR 7140157 A FR7140157 A FR 7140157A FR 2113883 B1 FR2113883 B1 FR 2113883B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7140157A
Other languages
French (fr)
Other versions
FR2113883A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of FR2113883A1 publication Critical patent/FR2113883A1/fr
Application granted granted Critical
Publication of FR2113883B1 publication Critical patent/FR2113883B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7140157A 1970-11-10 1971-11-09 Expired FR2113883B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9891970A JPS4920766B1 (en) 1970-11-10 1970-11-10

Publications (2)

Publication Number Publication Date
FR2113883A1 FR2113883A1 (en) 1972-06-30
FR2113883B1 true FR2113883B1 (en) 1975-08-01

Family

ID=14232524

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7140157A Expired FR2113883B1 (en) 1970-11-10 1971-11-09

Country Status (15)

Country Link
JP (1) JPS4920766B1 (en)
AR (1) AR193625A1 (en)
BE (1) BE775106A (en)
CA (1) CA951314A (en)
CH (1) CH559716A5 (en)
DD (1) DD95372A5 (en)
DE (1) DE2155546A1 (en)
DK (1) DK128733B (en)
ES (1) ES396708A1 (en)
FR (1) FR2113883B1 (en)
GB (1) GB1362956A (en)
HU (1) HU162848B (en)
NL (1) NL7115393A (en)
NO (1) NO133325C (en)
SU (1) SU433670A3 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163108A (en) * 1967-02-16 1979-07-31 Lever Brothers Company Prostaglandins
JPS4942648A (en) * 1972-08-24 1974-04-22
US3984424A (en) * 1972-11-08 1976-10-05 Pfizer Inc. P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
US3989736A (en) * 1973-01-08 1976-11-02 Pfizer Inc. Prostaglandin 5-indanyl esters
US3890372A (en) * 1974-01-08 1975-06-17 Upjohn Co Amino substituted phenyl and naphthyl esters of PGF{HD 2{301 {B - type compounds
US3968140A (en) * 1974-01-08 1976-07-06 The Upjohn Company Substituted anilide esters of PGE1
US3931281A (en) * 1974-01-08 1976-01-06 The Upjohn Company Substituted anilide ester of PGA2
US3948970A (en) * 1974-01-08 1976-04-06 The Upjohn Company Substituted tolyl esters of PGA1
US3969464A (en) * 1974-01-08 1976-07-13 The Upjohn Company Polycyclic aromatic esters of PGA1
US3987067A (en) * 1974-01-08 1976-10-19 The Upjohn Company Substituted aromatic esters of PGF2.sub.α
US3962289A (en) * 1974-01-08 1976-06-08 The Upjohn Company Esters of PGA2 and p-tritylphenol
US3932486A (en) * 1974-01-08 1976-01-13 The Upjohn Company Substituted tolyl esters of PGA2
US3959319A (en) * 1974-01-08 1976-05-25 The Upjohn Company Phenyl and naphthyl esters of PGF2 α type prostaglandins
US3931285A (en) * 1974-01-08 1976-01-06 The Upjohn Company Substituted tolyl esters of PGE1
US4013707A (en) * 1974-01-08 1977-03-22 The Upjohn Company Substituted phenyl esters of PGA1
US4013693A (en) * 1974-01-08 1977-03-22 The Upjohn Company Substituted phenyl esters of PGA1
US3988355A (en) * 1974-01-08 1976-10-26 The Upjohn Company Substituted phenyl and naphthyl esters of PGE1
US3998869A (en) * 1974-11-14 1976-12-21 The Upjohn Company Substituted anilide esters of 16-substituted PGE2
US4058551A (en) * 1974-12-12 1977-11-15 The Upjohn Company Substituted phenyl esters of PGA2
US4042606A (en) * 1974-12-12 1977-08-16 The Upjohn Company Substituted phenyl esters of PGA2
JPS5420344U (en) * 1977-07-13 1979-02-09
ATE227576T1 (en) 1988-09-06 2002-11-15 Pharmacia Ab PROSTAGLAND DERIVATIVES FOR THE TREATMENT OF GRAUNA OR OCCULAR HYPERTENSION
US20020106707A1 (en) 2000-08-07 2002-08-08 Marnett Lawrence J. Compositions and methods for detecting and quantifying COX-2 activity and anandamide metabolites
US7314709B2 (en) 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
CA2665081C (en) 2006-10-02 2015-12-01 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
JP5925158B2 (en) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin permeability
JP6030168B2 (en) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin permeability
JP6306067B2 (en) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin permeability
CN109400513B (en) * 2018-11-26 2020-06-09 武汉嘉诺康医药技术有限公司 Method for purifying carboprost

Also Published As

Publication number Publication date
NO133325B (en) 1976-01-05
SU433670A3 (en) 1974-06-25
DE2155546A1 (en) 1972-05-18
CH559716A5 (en) 1975-03-14
DK128733B (en) 1974-06-24
CA951314A (en) 1974-07-16
NO133325C (en) 1976-04-12
HU162848B (en) 1973-04-28
NL7115393A (en) 1972-05-15
ES396708A1 (en) 1975-04-16
JPS4920766B1 (en) 1974-05-27
BE775106A (en) 1972-03-01
AR193625A1 (en) 1973-05-11
DD95372A5 (en) 1973-02-05
FR2113883A1 (en) 1972-06-30
GB1362956A (en) 1974-08-07

Similar Documents

Publication Publication Date Title
NO133325C (en)
AU1473870A (en)
AU2044470A (en)
AU1146470A (en)
AU2085370A (en)
AU2130570A (en)
AU1517670A (en)
AU1326870A (en)
AU2017870A (en)
AU1336970A (en)
AU1716970A (en)
ATA672271A (en)
AU2119370A (en)
AU1943370A (en)
AU2144270A (en)
AU1591370A (en)
AU2131570A (en)
AU2130770A (en)
AU1689770A (en)
AU1581370A (en)
AU1328670A (en)
AU1969370A (en)
AU1603270A (en)
AU1974970A (en)
AU1343870A (en)

Legal Events

Date Code Title Description
ST Notification of lapse